Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthieu Resche-Rigon

Showing results (161-170 of 198) with videos related to

Pageof 20
Sort By:
Intensive Care Medicine|April 4, 2024
A randomised controlled trial of a nurse facilitator to promote communication for family members of critically ill patientsNancy Kentish-Barnes, Elie Azoulay, Jean Reignier, et al.
Annals of Intensive Care|June 14, 2017
Red blood cell transfusion in the resuscitation of septic patients with hematological malignanciesAdrien Mirouse, Matthieu Resche-Rigon, Virginie Lemiale, et al.
Journal of Critical Care|December 11, 2025
Survival after ICU discharge is shaped more by chronic disease than admission severityAlice Blet, Anouk Walter-Petrich, Ményssa Chérifa, et al.
Intensive Care Medicine|May 17, 2018
Impact of angiotensin-converting enzyme inhibitors or receptor blockers on post-ICU discharge outcome in patients with acute kidney injuryEtienne Gayat, Alexa Hollinger, Alain Cariou, et al.
The Lancet. Rheumatology|January 30, 2024
Safety and preliminary efficacy of allogeneic bone marrow-derived multipotent mesenchymal stromal cells for systemic sclerosis: a single-centre, open-label, dose-escalation, proof-of-concept, phase 1/2 studyDominique Farge, Séverine Loisel, Matthieu Resche-Rigon, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 27, 2019
Outcomes of Salvage Haploidentical Transplant with Post-Transplant Cyclophosphamide for Rescuing Graft Failure Patients: a Report on Behalf of the Francophone Society of Bone Marrow Transplantation and Cellular TherapyPedro H Prata, Matthieu Resche-Rigon, Didier Blaise, et al.
Critical Care Medicine|February 24, 2018
Endothelial Cell-Specific Molecule-1 in Critically Ill Patients With Hematologic MalignancyLara Zafrani, Matthieu Resche-Rigon, Nathalie De Freitas Caires, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 5, 2021
Phase I-II Open-Label Multicenter Study of Palbociclib + Vemurafenib in <i>BRAF</i> <sup>V600MUT</sup> Metastatic Melanoma Patients: Uncovering CHEK2 as a Major Response MechanismBaptiste Louveau, Matthieu Resche-Rigon, Thierry Lesimple, et al.
Intensive Care Medicine|August 2, 2011
Predictive factors of advanced interventional procedures in a multicentre severe postpartum haemorrhage studyEtienne Gayat, Matthieu Resche-Rigon, Olivier Morel, et al.
American Journal of Respiratory and Critical Care Medicine|September 20, 2018
Clinical Significance of Upper Airway Virus Detection in Critically Ill Hematology PatientsJérôme Legoff, Noémie Zucman, Virginie Lemiale, et al.
Pageof 20

Showing results (161-170 of 198) with videos related to

Sort By:
Pageof 20
Intensive Care Medicine|April 4, 2024
A randomised controlled trial of a nurse facilitator to promote communication for family members of critically ill patientsNancy Kentish-Barnes, Elie Azoulay, Jean Reignier, et al.
Annals of Intensive Care|June 14, 2017
Red blood cell transfusion in the resuscitation of septic patients with hematological malignanciesAdrien Mirouse, Matthieu Resche-Rigon, Virginie Lemiale, et al.
Journal of Critical Care|December 11, 2025
Survival after ICU discharge is shaped more by chronic disease than admission severityAlice Blet, Anouk Walter-Petrich, Ményssa Chérifa, et al.
Intensive Care Medicine|May 17, 2018
Impact of angiotensin-converting enzyme inhibitors or receptor blockers on post-ICU discharge outcome in patients with acute kidney injuryEtienne Gayat, Alexa Hollinger, Alain Cariou, et al.
The Lancet. Rheumatology|January 30, 2024
Safety and preliminary efficacy of allogeneic bone marrow-derived multipotent mesenchymal stromal cells for systemic sclerosis: a single-centre, open-label, dose-escalation, proof-of-concept, phase 1/2 studyDominique Farge, Séverine Loisel, Matthieu Resche-Rigon, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 27, 2019
Outcomes of Salvage Haploidentical Transplant with Post-Transplant Cyclophosphamide for Rescuing Graft Failure Patients: a Report on Behalf of the Francophone Society of Bone Marrow Transplantation and Cellular TherapyPedro H Prata, Matthieu Resche-Rigon, Didier Blaise, et al.
Critical Care Medicine|February 24, 2018
Endothelial Cell-Specific Molecule-1 in Critically Ill Patients With Hematologic MalignancyLara Zafrani, Matthieu Resche-Rigon, Nathalie De Freitas Caires, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 5, 2021
Phase I-II Open-Label Multicenter Study of Palbociclib + Vemurafenib in <i>BRAF</i> <sup>V600MUT</sup> Metastatic Melanoma Patients: Uncovering CHEK2 as a Major Response MechanismBaptiste Louveau, Matthieu Resche-Rigon, Thierry Lesimple, et al.
Intensive Care Medicine|August 2, 2011
Predictive factors of advanced interventional procedures in a multicentre severe postpartum haemorrhage studyEtienne Gayat, Matthieu Resche-Rigon, Olivier Morel, et al.
American Journal of Respiratory and Critical Care Medicine|September 20, 2018
Clinical Significance of Upper Airway Virus Detection in Critically Ill Hematology PatientsJérôme Legoff, Noémie Zucman, Virginie Lemiale, et al.
Pageof 20